Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 1 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 2 Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20171
20181
20211
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Not yet recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Assistance Publique - Hôpitaux de Paris1
Diamyd Medical AB1
Inreda Diabetic B.V.1
TikoMed AB1
University Hospital, Montpellier1
University Medical Center Groningen1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 110
Autoimmune Diseases2
Diabetes Mellitus2
Endocrine System Diseases2
Glucose Metabolism Disorders2
Immune System Diseases2
Metabolic Diseases2
Diabetic Nephropathies1
Hypoglycemia1
Insulin Resistance1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.